Who invested in Pionyr Immunotherapeutics?
Pionyr Immunotherapeutics's investors include New Enterprise Associates, OrbiMed, SV Health Investors and Mission BioCapital.
Funding summaryUpdated 26 Oct 2026
$275Mraised across 1 round since 2020, from 1 source
Pionyr Immunotherapeutics's investors include New Enterprise Associates, OrbiMed, SV Health Investors and Mission BioCapital.
Pionyr Immunotherapeutics has raised $275M across 1 round since 2020.
Pionyr Immunotherapeutics's most recent round was a Venture of $275M in Jun 2020.
Its most recent round, $275M in Jun 2020, is also its largest on record.
Pionyr Immunotherapeutics's first round on record, in Jun 2020, was backed by New Enterprise Associates, OrbiMed and SV Health Investors and 1 others.
Pionyr Immunotherapeutics's latest named round is a Venture, in Jun 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.